Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
238,153
+104,678
+78% +$590K ﹤0.01% 2695
2025
Q4
$707K Sell
133,475
-5,833
-4% -$26.1K ﹤0.01% 3660
2025
Q3
$641K Buy
139,308
+118,029
+555% +$475K ﹤0.01% 3646
2025
Q2
$70.4K Sell
21,279
-259,706
-92% -$675K ﹤0.01% 4652
2025
Q1
$826K Hold
280,985
﹤0.01% 3219
2024
Q4
$809K Sell
280,985
-468,532
-63% -$1.3M ﹤0.01% 3519
2024
Q3
$2.08M Sell
749,517
-452,620
-38% -$1.1M ﹤0.01% 2817
2024
Q2
$2.85M Buy
+1,202,137
New +$2.63M ﹤0.01% 1885
2022
Q3
Sell
-168,103
Closed -$503K 5077
2022
Q2
$503K Buy
+168,103
New +$495K ﹤0.01% 2844

Other funds holding RERE

Barclays's RERE Position: Q1 2026 in Review

Barclays increased its ATRenew (RERE) stake by 78% in Q1 2026, buying an estimated $590K and bringing the position to 238,153 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

Barclays first reported a position in RERE in Q2 2022 and has held it in 9 quarters since. The position peaked at $2.85M in Q2 2024. 81 funds tracked by Wall St. Rank hold RERE as of Q1 2026.

  • Barclays held 238,153 shares of ATRenew worth $1.12M as of Q1 2026.
  • Barclays bought 104,678 ATRenew shares in Q1 2026, an estimated $590K.
  • ATRenew made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2695 holding.
  • Barclays first reported a position in ATRenew in Q2 2022 and has held it in 9 quarters since.
  • Barclays's ATRenew position peaked at $2.85M in Q2 2024.
  • 81 funds tracked by Wall St. Rank held ATRenew as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.